Edition:
United States

Capricor Therapeutics Inc (CAPR.OQ)

CAPR.OQ on NASDAQ Stock Exchange Capital Market

1.34USD
25 May 2018
Change (% chg)

$-0.01 (-0.74%)
Prev Close
$1.35
Open
$1.36
Day's High
$1.36
Day's Low
$1.33
Volume
6,816
Avg. Vol
63,618
52-wk High
$4.25
52-wk Low
$0.63

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 0.40 -0.136
FY 2017 Dec '17 0.48 0.306
Sep '17 0.31 -0.117
Jun '17 1.00 -0.157
Mar '17 0.88 -0.171
FY 2016 Dec '16 0.91 -0.211
Sep '16 0.75 -0.292
Jun '16 1.13 -0.261
Mar '16 1.22 -0.258
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 2 0.20 0.41 0.00 --
Quarter Ending Sep-18 2 0.45 0.90 0.00 --
Year Ending Dec-18 2 1.55 2.70 0.40 6.90
Year Ending Dec-19 2 1.40 2.80 0.00 7.00
Earnings (per share)
Quarter Ending Jun-18 2 -0.12 -0.12 -0.13 --
Quarter Ending Sep-18 2 -0.12 -0.11 -0.14 --
Year Ending Dec-18 2 -0.50 -0.48 -0.53 -0.83
Year Ending Dec-19 2 -0.44 -0.44 -0.45 -0.84
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 20.48 243.17 32.94
P/E High - Last 5 Yrs. 17.41 292.19 47.16
P/E Low - Last 5 Yrs. 17.41 100.20 24.79
Beta -3.15 0.75 0.78
Price to Sales (TTM) 17.35 250.73 8.13
Price to Book (MRQ) 3.58 24.24 4.34
Price to Tangible Book (MRQ) 3.63 27.23 5.84
Price to Cash Flow (TTM) 14.78 138.95 22.00
% Owned Institutions 4.28 10.82 2.41

Dividends

  Company industry sector
Dividend Yield -- 0.30 1.65
Dividend Yield - 5 Year Avg -- 0.20 0.79
Dividend 5 Year Growth Rate -- 2.32 4.02
Payout Ratio(TTM) 0.00 46.60 17.43

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -54.58 26.35 5.00
Sales (TTM) vs TTM 1 Yr. Ago -40.35 146.21 12.76
Sales - 5 Yr. Growth Rate 7.03 30.96 8.13
EPS (MRQ) vs Qtr. 1 Yr. Ago 20.36 -92.15 35.26
EPS (TTM) vs TTM 1 Yr. Ago 88.84 -- --
EPS - 5 Yr. Growth Rate -- 48.60 8.59
Capital Spending - 5 Yr. Growth Rate -20.75 40.09 8.63

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.64 2.53
Current Ratio (MRQ) 9.89 6.56 3.61
LT Debt to Equity (MRQ) 32.05 22.15 12.75
Total Debt to Equity (MRQ) 32.05 25.59 15.82
Interest Coverage (TTM) -43.47 -176.29 35.70

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.28 54.92
Gross Margin - 5 Yr. Avg. -- 55.13 52.70
EBITD Margin (TTM) -587.64 -- --
EBITD - 5 Yr. Avg -314.28 -151.01 15.95
Operating Margin (TTM) 122.22 -874.91 0.17
Operating Margin - 5 Yr. Avg. -246.88 -163.69 11.24
Pre-Tax Margin (TTM) 111.02 -763.70 2.21
Pre-Tax Margin - 5 Yr. Avg. -253.78 -168.55 11.46
Net Profit Margin (TTM) 111.02 -755.33 -1.22
Net Profit Margin - 5 Yr. Avg. -253.78 -168.17 7.75
Effective Tax Rate (TTM) -- 14.79 31.16
Effective Tax Rate - 5 Yr. Avg. -- 19.57 24.29

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 22,221,672 732,879,315
Net Income/Employee (TTM) -- -806,425 85,224,914
Receivable Turnover (TTM) 8.67 17.43 5.88
Inventory Turnover (TTM) -- 2.45 3.58
Asset Turnover (TTM) 0.15 0.42 0.86

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 16.48 -5.15 10.13
Return on Assets - 5 Yr. Avg. -68.39 -0.29 11.15
Return on Investment (TTM) 19.66 -7.30 12.79
Return on Investment - 5 Yr. Avg. -100.87 3.03 14.43
Return on Equity (TTM) 145.19 -10.05 14.67
Return on Equity - 5 Yr. Avg. -- -2.71 15.77
  1 Year 3 Year 5 Year
Sales % -33.32 -17.72 7.03
EPS (TTM) % 108.95 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Capricor Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 1.50 -0.76 99 66
13 Week -25.41 -26.07 34 45
26 Week -35.71 -38.79 31 87
52 Week 70.24 50.06 99 88
YTD -14.56 -16.25 68 85
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 4.28%
# of Holders: 23
Total Shares Held: 1,247,319
3 Mo. Net Change: -1,183,710
# New Positions: 4
# Closed Positions: 6
# Increased Positions: 6
# Reduced Positions: 10
# Net Buyers: -4
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.